Saturday, 21 July 2018


Kemin Launches Immunomodulator Product for Poultry

Aleta™ is a revolutionary algae-based immunomodulator for optimal animal health
News provided by, Kemin Industries: – Kemin Industries, a global nutritional ingredient company that uses science to create solutions and products that touch half the world’s population, has launched its next-generation immunomodulator product for poultry, Aleta™, in India.

The product was launched by Dr. Chris Nelson, President and CEO of Kemin, along with
Dr. Geoff Horst, Research and Development Lead for Animal Nutrition and Health, North America, Mr. G. S. Ramesh, Group President of Animal Nutrition and Health, Dr. R. Sureshkumar, President of Animal Nutrition and Health, India and local Kemin employees.

Following the launch, Dr. Nelson, Dr. Horst and Mr. Ramesh held a global live webcast on “Immu-nnovation in Poultry”. The group had a detailed discussion on the science of the immunomodulator, the uniqueness of Beta Glucan for optimizing animal health and why Aleta is the next-generation solution for animal health. More than 100 participants worldwide watched the webcast, which can be viewed here.

“Kemin recognizes antibiotic replacement as a key focus of our customers and the industry. When we look at scientific literature, there are basically six different technologies proven to be the best alternatives to antibiotics,” said Dr. Nelson during the event. “Prior to Aleta, Kemin already had four technologies that are globally recognized and proven to be effective antibiotic alternatives. With Aleta, we now have an immunomodulator technology for our antibiotic alternative portfolio in animals.”

In March, Kemin acquired a unique linear 1,3 ß-glucan (Beta-Glucan) manufacturing technology, developed by Algal Scientific. With Aleta, Kemin offers immunomodulator technology that is not only revolutionary but also the safest and most effective product available today in the market, said Dr. Nelson.

Aleta is a pure and highly bioavailable immunomodulator offering a high and consistent concentration of linear 1,3 ß-glucan to improve immunity and animal performance. Aleta provides a consistent ROI in situations of immune and stress challenges.

During the webcast, Dr. Horst explained the uniqueness of Aleta and how it stands out from yeast-based Beta Glucan in the market. Key points included:

• High concentration compared to yeast based ß-glucans
• Linear 1,3 ß-glucan from algae has superior immune response compared to 1,6 ß-glucans derived from yeast
• Standardized and quantifiable ß-glucan
• Highly bioavailable ß-glucan
• More consistent immunomodulator activity
• Safe product (no dioxin, no ionophore contamination)

To learn more about Aleta, please visit or view the webcast here.